PEX11B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.261400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.467000E-01
Normal-vs-Stage2
5.423800E-01
Normal-vs-Stage3
4.077000E-01
Normal-vs-Stage4
2.336000E-01
Stage1-vs-Stage2
5.615600E-01
Stage1-vs-Stage3
9.909600E-02
Stage1-vs-Stage4
3.789800E-01
Stage2-vs-Stage3
1.037030E-01
Stage2-vs-Stage4
5.650100E-02
Stage3-vs-Stage4
9.181900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.612000E-01
Normal-vs-AfricanAmerican
3.737000E-01
Normal-vs-Asian
3.946800E-01
Caucasian-vs-AfricanAmerican
8.324000E-01
Caucasian-vs-Asian
9.867400E-01
AfricanAmerican-vs-Asian
7.762000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.399400E-01
Normal-vs-Female
5.347000E-01
Male-vs-Female
7.394800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.648600E-01
Normal-vs-Age(41-60Yrs)
3.291200E-01
Normal-vs-Age(61-80Yrs)
6.489600E-01
Normal-vs-Age(81-100Yrs)
3.740600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.089400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.351600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.599800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.620800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.440600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.422600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.371400E-01
Normal-vs-Daily Drinker
7.907000E-01
Normal-vs-Weekly Drinker
4.319400E-01
Normal-vs-Occasional Drinker
1.914770E-01
Normal-vs-Social Drinker
4.733000E-01
Non Drinker-vs-Daily Drinker
5.039400E-01
Non Drinker-vs-Weekly Drinker
3.732200E-01
Non Drinker-vs-Occasional Drinker
2.624400E-01
Non Drinker-vs-Social Drinker
5.940200E-01
Daily Drinker-vs-Weekly Drinker
2.132000E-01
Daily Drinker-vs-Occasional Drinker
1.047230E-01
Daily Drinker-vs-Social Drinker
7.882200E-01
Weekly Drinker-vs-Occasional Drinker
9.618600E-01
Weekly Drinker-vs-Social Drinker
2.799000E-01
Occasional Drinker-vs-Social Drinker
8.779900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.150300E-02
Normal-vs-Grade 2
4.522400E-03
Normal-vs-Grade 3
1.523660E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.205500E-02
Grade 1-vs-Grade 3
2.216100E-02
Grade 1-vs-Grade 4
2.150300E-02
Grade 2-vs-Grade 3
5.070800E-01
Grade 2-vs-Grade 4
4.522400E-03
Grade 3-vs-Grade 4
1.523660E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.504400E-01
Normal-vs-NonDiabetic
3.657600E-01
Diabetic-vs-NonDiabetic
4.814400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.739000E-01
Normal-vs-NoPancreatitis
5.433800E-01
Pancreatitis-vs-NoPancreatitis
8.877400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.556600E-01
Normal-vs-N1
5.857800E-01
N0-vs-N1
3.065400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.170430E-01
Normal-vs-TP53-NonMutant
4.297400E-01
TP53-Mutant-vs-TP53-NonMutant
5.154200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
